BRUIN MCL-321: Phase III Study of Pirtobrutinib Versus Investigator Choice of BTK Inhibitor in BTK Inhibitor Naive Mantle Cell Lymphoma
Future Oncology | November 15, 2022 | Volume: 18 | Issue: 36 | Pages: 3961-3969
10.2217/fon-2022-0976
| PMID 36377973